首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of parkinsons disease

缩写:J PARKINSON DIS

ISSN:1877-7171

e-ISSN:1877-718X

IF/分区:5.0/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1756
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Julita Chlebowicz,Violetta Ivanova,Jacqueline Burré Julita Chlebowicz
Parkinson's disease (PD) is characterized by progressive motor and non-motor dysfunction arising from synaptic pathology that precedes neuronal loss. Synaptic dysfunction represents a central pathological mechanism in both familial and spor...
Sacha E Gandhi,Katherine A Grosset,Prasanth A Iruthayaraj et al. Sacha E Gandhi et al.
BackgroundOsteoporosis and major osteoporotic fracture are more common in PD than controls, but evaluation of sociodemographic factors and preventive treatment is limited.MethodsIn a UK population-based nested case-control study, incidence ...
Preston Dang,Ziyue Luo,Xiecheng Chen et al. Preston Dang et al.
IntroductionDespite being the fastest-growing ethnic group in the United States, Asian Americans, encompassing all ethnic subgroups, remain notably underrepresented in Parkinson's Disease (PD) research and clinical trials. This qualitative ...
Zhengting Yang,Sufang Liu,Li Wang et al. Zhengting Yang et al.
BackgroundThis study aimed to use data from the PD-MDCNC database to develop a risk prediction model using machine learning (ML) methods for the early identification of the risk of mild cognitive impairment in Parkinson's disease (PD-MCI) w...
Leslie C Kirsch,Emily Baxi,Mukta Phatak et al. Leslie C Kirsch et al.
Effective sharing of large datasets across traditionally siloed research domains has the power to transform conventional research practice dramatically, but has been stymied by persistent barriers to data access and interoperability. The 20...
N Pavese,J Evans,A Hand et al. N Pavese et al.
BackgroundLevodopa is still the cornerstone of symptomatic treatment for people with Parkinson's disease (PwP). With disease progression and long-term use, PwP can develop motor complications such as wearing off and dyskinesia. There is lim...
Artur Fs Schuh,Leonidas Stefanis Artur Fs Schuh
We comment here on the recently published paper by Ostentag et al., 2026, which examined self-reported environmental exposures in a group of patients with Parkinson's Disease (PD). Patients with GBA1-associated Parkinson's Disease (PD) were...
Anjali Sivaramakrishnan,Meenal Cascella,Samantha Hauck et al. Anjali Sivaramakrishnan et al.
BackgroundHigh intensity interval training (HIIT) involves vigorous intensity exercise bouts interspersed with low intensity bouts. Despite growing interest, the optimal dosage and clinical adaptability of HIIT in Parkinson's disease (PD) r...
Simon Jg Lewis Simon Jg Lewis
Over the past 25 years, a prevailing clinical dogma has held that significant cognitive impairment constitutes a contraindication to the use of Deep Brain Stimulation in Parkinson's disease. Whilst multiple studies, excluding such patients,...
Camryn R Marshall,VyVy N Young,Zoe Weston et al. Camryn R Marshall et al.
ObjectiveParkinson's disease (PD) frequently involves dysphagia, yet real-world longitudinal data capturing its progression and response to clinical care remain limited. Most prior studies exclude treated patients or rely solely on subjecti...